Edition:
United Kingdom

Imprimis Pharmaceuticals Inc (IMMY.OQ)

IMMY.OQ on NASDAQ Stock Exchange Capital Market

3.32USD
18 Oct 2018
Change (% chg)

-- (--)
Prev Close
$3.32
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
31,967
52-wk High
$3.61
52-wk Low
$1.35

Chart for

About

Imprimis Pharmaceuticals, Inc. (Imprimis) is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company, through... (more)
No analyst recommendations are available for .

Overall

Beta: -0.61
Market Cap(Mil.): $34.31
Shares Outstanding(Mil.): 20.07
Dividend: --
Yield (%): --

Financials

  IMMY.OQ Industry Sector
P/E (TTM): -- 85.68 33.65
EPS (TTM): -0.93 -- --
ROI: -69.45 0.45 14.28
ROE: -203.32 1.37 16.00

Competitors

  Price Chg
Eli Lilly And Co (LLY.N) $113.31 --
Sanofi SA (SASY.PA) €77.70 -0.10
Bayer AG (BAYGn.DE) €78.09 -0.33
Bayer AG (BAYE.F) -- --
Roche Holding Ltd. (ROG.S) CHF243.35 +4.80
Roche Holding Ltd. (RO.S) CHF244.00 +4.60
Merck & Co., Inc. (MRK.N) $72.21 --
Novartis AG (NOVN.S) CHF86.52 +0.64

Earnings vs. Estimates